Amicus Therapeutics (FOLD) had the highest return between July 1, 2014 and December 31, 2014 by a mid-cap US stock, returning 124.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Amicus Therapeutics (FOLD) | 7/1/2014 - 12/31/2014 | 124.86% |
Xenon Pharmaceuticals (XENE) | 7/1/2014 - 12/31/2014 | 97.11% |
PTC Therapeutics (PTCT) | 7/1/2014 - 12/31/2014 | 96.92% |
Ocular Therapeutix (OCUL) | 7/1/2014 - 12/31/2014 | 80.92% |
Paycom Software (PAYC) | 7/1/2014 - 12/31/2014 | 80.1% |
Qorvo (QRVO) | 7/1/2014 - 12/31/2014 | 72.81% |
Green Brick Partners (GRBK) | 7/1/2014 - 12/31/2014 | 72.07% |
TG Therapeutics (TGTX) | 7/1/2014 - 12/31/2014 | 68.33% |
Enphase Energy (ENPH) | 7/1/2014 - 12/31/2014 | 68.32% |
Cytokinetics (CYTK) | 7/1/2014 - 12/31/2014 | 66.88% |
ADEIA (ADEA) | 7/1/2014 - 12/31/2014 | 63.62% |
Ambarella (AMBA) | 7/1/2014 - 12/31/2014 | 61.07% |
Century Aluminum (CENX) | 7/1/2014 - 12/31/2014 | 54.63% |
Skyworks Solutions (SWKS) | 7/1/2014 - 12/31/2014 | 54.47% |
Perdoceo Education (PRDO) | 7/1/2014 - 12/31/2014 | 48.4% |
Bath & Body Works (BBWI) | 7/1/2014 - 12/31/2014 | 48.24% |
Trex (TREX) | 7/1/2014 - 12/31/2014 | 47.69% |
Norwegian Cruise Line (NCLH) | 7/1/2014 - 12/31/2014 | 47.41% |
Qualys (QLYS) | 7/1/2014 - 12/31/2014 | 46.03% |
Phibro Animal Health (PAHC) | 7/1/2014 - 12/31/2014 | 44.84% |
Installed Building Products (IBP) | 7/1/2014 - 12/31/2014 | 44.76% |
Vicor (VICR) | 7/1/2014 - 12/31/2014 | 43.71% |
Knight Transportation (KNX) | 7/1/2014 - 12/31/2014 | 41.78% |
Murphy USA (MUSA) | 7/1/2014 - 12/31/2014 | 40.73% |
ACADIA Pharmaceuticals (ACAD) | 7/1/2014 - 12/31/2014 | 40.11% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
